Sheaff Brock Investment Advisors LLC Boosts Stake in Aurora Cannabis Inc (NYSE:ACB)

Sheaff Brock Investment Advisors LLC lifted its position in Aurora Cannabis Inc (NYSE:ACB) by 56.4% in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 18,680 shares of the company’s stock after purchasing an additional 6,740 shares during the quarter. Sheaff Brock Investment Advisors LLC’s holdings in Aurora Cannabis were worth $146,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of ACB. Moisand Fitzgerald Tamayo LLC purchased a new position in shares of Aurora Cannabis in the 1st quarter worth about $25,000. Carroll Financial Associates Inc. purchased a new position in shares of Aurora Cannabis in the 1st quarter worth about $27,000. Mackey Komara & Dankovich LLC purchased a new position in shares of Aurora Cannabis in the 2nd quarter worth about $27,000. Financial Management Professionals Inc. boosted its holdings in shares of Aurora Cannabis by 586.3% in the 1st quarter. Financial Management Professionals Inc. now owns 3,061 shares of the company’s stock worth $28,000 after purchasing an additional 2,615 shares in the last quarter. Finally, Burt Wealth Advisors boosted its holdings in shares of Aurora Cannabis by 1,033.3% in the 1st quarter. Burt Wealth Advisors now owns 3,400 shares of the company’s stock worth $31,000 after purchasing an additional 3,100 shares in the last quarter. Hedge funds and other institutional investors own 9.10% of the company’s stock.

A number of equities analysts have recently issued reports on ACB shares. Desjardins started coverage on Aurora Cannabis in a report on Thursday, April 25th. They issued a “buy” rating and a $9.07 price objective for the company. Piper Jaffray Companies started coverage on Aurora Cannabis in a report on Monday. They issued a “neutral” rating and a $7.00 price objective for the company. Bank of America cut Aurora Cannabis from a “buy” rating to a “neutral” rating and set a $7.30 price objective for the company. in a report on Thursday, July 18th. LADENBURG THALM/SH SH started coverage on Aurora Cannabis in a report on Wednesday, July 17th. They issued a “buy” rating and a $9.00 price objective for the company. Finally, Zacks Investment Research cut Aurora Cannabis from a “buy” rating to a “sell” rating in a report on Thursday. One research analyst has rated the stock with a sell rating, six have issued a hold rating and five have issued a buy rating to the stock. Aurora Cannabis has an average rating of “Hold” and an average price target of $8.23.



ACB stock traded up $0.39 during trading on Friday, hitting $6.06. 5,911,245 shares of the company traded hands, compared to its average volume of 13,077,470. The firm has a market capitalization of $6.78 billion, a PE ratio of 50.47 and a beta of 2.44. Aurora Cannabis Inc has a 1 year low of $4.58 and a 1 year high of $12.52. The company has a 50-day moving average of $6.87 and a 200-day moving average of $7.89. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.98 and a current ratio of 2.37.

Aurora Cannabis (NYSE:ACB) last issued its earnings results on Tuesday, May 14th. The company reported ($0.08) earnings per share for the quarter, missing the consensus estimate of ($0.03) by ($0.05). The company had revenue of $49.00 million for the quarter, compared to analysts’ expectations of $50.92 million. Aurora Cannabis had a negative net margin of 122.65% and a positive return on equity of 1.24%. Sell-side analysts expect that Aurora Cannabis Inc will post -0.23 EPS for the current year.

About Aurora Cannabis

Aurora Cannabis Inc produces and distributes medical cannabis products. It is vertically integrated and horizontally diversified across various segments of the cannabis value chain, from facility engineering and design to cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution.

Recommended Story: What Factors Can Affect Return on Equity?

Institutional Ownership by Quarter for Aurora Cannabis (NYSE:ACB)

Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.